eClinical Tech News

Biosyent Inc. reports robust financial results for Q2 and H1 2025, demonstrating consistent growth across its Canadian pharmaceutical, international...

Telix Pharmaceuticals reported strong H1 2025 results, with a 63% year-over-year revenue increase to $390.4 million, keeping the company...

Ascentage Pharma’s H1 2025 results reveal a company navigating a complex transition, marked by soaring sales of its flagship...

Ascentage Pharma’s H1 2025 results reveal a company navigating a complex landscape of commercial growth and pipeline advancement, underscored...

Novabay Pharmaceuticals has secured a $6 million investment from private investor David E. Lazar, marking a pivotal shift for...

Novabay Pharmaceuticals, securing a $6 million investment from private investor David E. Lazar, has opted for a strategic pivot...

HCW Biologics Navigates Challenging Biotech Funding Landscape with Strategic Moves HCW Biologics, a clinical-stage biopharmaceutical company focused on immunotherapies...

Cosmos Health Inc., a global healthcare conglomerate, reported double-digit revenue growth for Q2 2025, reaching $14.75 million, an 11.66%...

NRx Pharmaceuticals Doubles Down on Ketamine for Suicidal Depression, Secures Strategic Investment NRx Pharmaceuticals is aggressively pursuing a dual-pronged...

Pelthos Therapeutics (NYSE American: PTHS) has officially launched Zelsuvmi™ (berdazimer) topical gel 10.3%, the first FDA-approved at-home treatment for...